Loading...
MedAdvisor Limited
MDR.AX•ASX
Healthcare
Medical - Healthcare Information Services
A$0.07
A$-0.01(-11.39%)
MedAdvisor Limited (MDR.AX) Financial Performance & Income Statement Overview
Review MedAdvisor Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
24.64%
↑ 24.64%
Operating Income Growth
134.95%
↑ 134.95%
Net Income Growth
107.007%
↑ 107.007%
Operating Cash Flow Growth
456.78%
↑ 456.78%
Operating Margin
6.77%
↑ 6.77%
Gross Margin
19.53%
↑ 19.53%
Net Profit Margin
-4.51%
↓ 4.51%
ROE
-8.66%
↓ 8.66%
ROIC
9.17%
↑ 9.17%
MedAdvisor Limited (MDR.AX) Income Statement & Financial Overview
Review MedAdvisor Limited's (MDR.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $46.56M | $75.55M | $33.88M | $64.08M |
| Cost of Revenue | $39.24M | $57.11M | $36.50M | $48.65M |
| Gross Profit | $7.31M | $18.44M | -$2.62M | $15.43M |
| Gross Profit Ratio | $0.16 | $0.24 | -$0.08 | $0.24 |
| R&D Expenses | $0.00 | $0.00 | $4.004M | $3.50M |
| SG&A Expenses | $7.56M | $10.27M | $7.57M | $6.17M |
| Operating Expenses | $7.56M | $10.27M | $11.57M | $9.67M |
| Total Costs & Expenses | $46.80M | $67.38M | $48.08M | $58.32M |
| Interest Income | $99156.00 | $56970.00 | $24410.00 | $27101.00 |
| Interest Expense | $836607.00 | $1.09M | $942022.00 | $1.19M |
| Depreciation & Amortization | $262908.00 | $2.16M | $2.55M | $2.80M |
| EBITDA | -$5.12M | $10.33M | -$11.62M | $8.56M |
| EBITDA Ratio | -$0.11 | $0.14 | -$0.34 | $0.13 |
| Operating Income | -$245346.00 | $8.17M | -$14.19M | $5.76M |
| Operating Income Ratio | -$0.005 | $0.11 | -$0.42 | $0.09 |
| Other Income/Expenses (Net) | -$5.97M | -$1.04M | -$917610.00 | -$1.16M |
| Income Before Tax | -$6.21M | $7.14M | -$15.11M | $4.60M |
| Income Before Tax Ratio | -$0.13 | $0.09 | -$0.45 | $0.07 |
| Income Tax Expense | -$132590.00 | $264040.00 | $789877.00 | $1.00 |
| Net Income | -$6.08M | $6.87M | -$15.90M | $4.60M |
| Net Income Ratio | -$0.13 | $0.09 | -$0.47 | $0.07 |
| EPS | -$0.01 | $0.01 | -$0.03 | $0.009 |
| Diluted EPS | -$0.01 | $0.01 | -$0.03 | $0.009 |
| Weighted Avg Shares Outstanding | $549.95M | $546.31M | $535.61M | $513.91M |
| Weighted Avg Shares Outstanding (Diluted) | $598.50M | $595.75M | $535.61M | $540.63M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan